Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis

Abstract

ABX464 represents a novel class of anti-HIV molecules with unique properties. ABX464 has a long lasting effect in humanized mice and neutralizes the expression of HIV-1 proviral genome of infected immune cells including reservoirs and it is therefore a promising drug toward a functional cure of HIV.